drugset / Trial / NCT01415531
Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the efficacy, safety, and tolerability of 8 weeks of therapy with nebivolol in comparison to placebo in younger patients 18 - 54 years of age with stage 1 or stage 2 essential hypertension.
Timeline
- Start
- 2011-08
- Primary completion
- 2012-03
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nebivolol | Other / unclassified | 5 mg | Oral |
| Subject | Nebivolol | Other / unclassified | 10 mg | Oral |
| Subject | Nebivolol | Other / unclassified | 20 mg | Oral |